Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

MYTREX A

NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE

Standard Dose
EQ 3.5MG BASE/GM;0.1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MYTREX A is listed in Drugs@FDA under application 062609 (ANDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE Form and strength OINTMENT;TOPICAL - EQ 3.5MG BASE/GM;0.1% Sponsor SAVAGE LABS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview MYTREX A is listed in Drugs@FDA under application 062609 (ANDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE Form and strength OINTMENT;TOPICAL - EQ 3.5MG BASE/GM;0.1% Sponsor SAVAGE LABS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
MYTREX A (NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE) | Drug Monograph | MedicHelpline